Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04734041 · ClinicalTrials.gov registry record · NA
Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)
A NA study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04734041 is a NA study that has completed, run by National University of Natural Medicine. The registered enrollment target is 20 participants.
The verdict
NCT04734041, a NA study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)
Interventions
- BEHAVIORAL Anti-inflammatory (Mediterranean-style) diet
- BEHAVIORAL Behavioral and psychosocial support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2021-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04734041
The ClinicalTrials.gov registry entry for NCT04734041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National University of Natural Medicine, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Anti-inflammatory (Mediterranean-style) diet is the first listed.
NCT04734041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04734041 about?
NCT04734041 is a clinical study titled "Integrative Medicine for Hypermobility Spectrum Disorder and Ehlers-Danlos Syndromes (IMforHSDandEDS)". A feasibility study of an integrative medicine program among patients with Hypermobility Spectrum Disorder (HSD) or Ehlers-Danlos syndromes (EDS)
What is the current status of trial NCT04734041?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-12-23. Estimated completion is 2021-07-02.
What interventions are being tested in trial NCT04734041?
The interventions under investigation include: Anti-inflammatory (Mediterranean-style) diet (BEHAVIORAL), Behavioral and psychosocial support (BEHAVIORAL).
Who is sponsoring clinical trial NCT04734041?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.